The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.


Updates from The Motley Fool

Latest updates on Sunesis Pharmaceuticals from Fool.com.
3 Biotechs Burning Through Cash

Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry do...

3 Winners From QE3

With the Federal Reserve committing to buy $85 billion worth of securities every more -- includin...

Wall Street's Best Hidden Stocks

When asked for the secret of his success, baseball player Wee Willie Keeler replied, "Hit 'em whe...

Hidden Stocks for High Returns

Like the song says, investors are looking for stocks to love in all the wrong places . They'll ...

3 Top Stocks at Half-Price

You love buying your shirts when they go on sale. And who can resist a buy-one-get-one-free offer...



Stock Performance

View Interactive SNSS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sunesis Pharmaceuticals.
Current Price: $4.04
Prev Close: $3.90
Open: $3.93
Bid: $4.03
Ask: $4.04
Day's Range: $3.93 - $4.07
52wk Range: $2.63 - $6.30
Volume: 12,822
Avg Vol 50,225
Market Cap: $305M
P/E (ttm): -1.33
EPS (ttm): ($2.94)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sunesis Pharmaceuticals.
CAPS Rating 2 out of 5
 
82 Outperform
21 Underperform
CAPS All Stars
 
24 Outperform
12 Underperform

How do you think Sunesis Pharmaceuticals will perform against the market?



You pick for Sunesis Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dan Swisher Jr., CEO

83% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sunesis Pharmaceuticals.

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers